GetTopicDetailResponse(id=faa91641223, topicName=SLICC, introduction=SLICC, content=null, image=null, comments=4, allHits=936, url=https://h5.medsci.cn/topic?id=16412, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=97163, tagList=[TagDto(tagId=97163, tagName=SLICC)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1794120, encodeId=7c251e94120e3, content=<a href='/topic/show?id=faa91641223' target=_blank style='color:#2F92EE;'>#SLICC#</a>, objectTitle=SLICC 隊(duì)列研究證實(shí)：羥氯喹能夠降低狼瘡發(fā)作的風(fēng)險(xiǎn), objectType=article, longId=736085, objectId=d10ae36085e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10ae36085e1, replyNumber=0, likeNumber=101, createdTime=2023-04-22, rootId=0, userName=xiongke010, userId=ce68183, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10ae36085e1, moduleTitle=SLICC 隊(duì)列研究證實(shí)：羥氯喹能夠降低狼瘡發(fā)作的風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d10ae36085e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1794118, encodeId=d24c1e9411885, content=<a href='/topic/show?id=faa91641223' target=_blank style='color:#2F92EE;'>#SLICC#</a>, objectTitle=ARD: 羥氯喹減少或停藥后的發(fā)作：系統(tǒng)性狼瘡國際合作診所 (SLICC) 初始隊(duì)列的結(jié)果, objectType=article, longId=293699, objectId=478b2936991c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=478b2936991c, replyNumber=0, likeNumber=139, createdTime=2022-08-29, rootId=0, userName=xiongke010, userId=ce68183, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=478b2936991c, moduleTitle=ARD: 羥氯喹減少或停藥后的發(fā)作：系統(tǒng)性狼瘡國際合作診所 (SLICC) 初始隊(duì)列的結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=478b2936991c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1794119, encodeId=d7131e9411968, content=<a href='/topic/show?id=faa91641223' target=_blank style='color:#2F92EE;'>#SLICC#</a>, objectTitle=ARD：系統(tǒng)性狼瘡國際合作診所 (SLICC) 初始隊(duì)列中抗核抗體ANA的縱向分析, objectType=article, longId=301935, objectId=ab58301935de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab58301935de, replyNumber=0, likeNumber=114, createdTime=2022-09-23, rootId=0, userName=xiongke010, userId=ce68183, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab58301935de, moduleTitle=ARD：系統(tǒng)性狼瘡國際合作診所 (SLICC) 初始隊(duì)列中抗核抗體ANA的縱向分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ab58301935de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1794117, encodeId=d1cc1e94117b2, content=<a href='/topic/show?id=faa91641223' target=_blank style='color:#2F92EE;'>#SLICC#</a>, objectTitle=Arthritis Rheumatol：使用系統(tǒng)性狼瘡國際合作診所虛弱指數(shù)（SLICC-FI）預(yù)測(cè)SLE損害, objectType=article, longId=183648, objectId=48fc18364847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48fc18364847, replyNumber=0, likeNumber=107, createdTime=2020-11-11, rootId=0, userName=xiongke010, userId=ce68183, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48fc18364847, moduleTitle=Arthritis Rheumatol：使用系統(tǒng)性狼瘡國際合作診所虛弱指數(shù)（SLICC-FI）預(yù)測(cè)SLE損害, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=48fc18364847)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
